| A combinatorial delivery of survivin targeted siRNA using cancer selective nanoparticles for triple negative breast cancer therapy P Kesharwani, A Sheikh, MAS Abourehab, R Salve, V Gajbhiye Journal of Drug Delivery Science and Technology 80, 104164, 2023 | 36 | 2023 |
| Stimuli-responsive mesoporous silica nanoparticles: A custom-tailored next generation approach in cargo delivery R Salve, P Kumar, W Ngamcherdtrakul, V Gajbhiye, W Yantasee Materials Science and Engineering: C 124, 112084, 2021 | 33 | 2021 |
| Biodegradable dendritic Boltorn™ nanoconstructs: A promising avenue for cancer theranostics S Korake, A Shaikh, R Salve, KR Gajbhiye, V Gajbhiye, A Pawar International Journal of Pharmaceutics 594, 120177, 2021 | 20 | 2021 |
| Nucleolin aptamer conjugated MSNPs-PLR-PEG multifunctional nanoconstructs for targeted co-delivery of anticancer drug and siRNA to counter drug resistance in TNBC P Kumar, R Salve, KM Paknikar, V Gajbhiye International Journal of Biological Macromolecules 229, 600-614, 2023 | 14 | 2023 |
| GLUT1 transporter-facilitated solid lipid nanoparticles loaded with anti-cancer therapeutics for ovarian cancer targeting S Jagdale, M Narwade, A Sheikh, S Md, R Salve, V Gajbhiye, ... International Journal of Pharmaceutics 637, 122894, 2023 | 13 | 2023 |
| Lipid polymer hybrid nanoparticles: a custom-tailored next-generation approach for cancer therapeutics KR Gajbhiye, R Salve, M Narwade, A Sheikh, P Kesharwani, V Gajbhiye Molecular Cancer 22 (1), 160, 2023 | 12 | 2023 |
| Aptamer tethered bio-responsive mesoporous silica nanoparticles for efficient targeted delivery of paclitaxel to treat ovarian cancer cells R Salve, P Kumar, BP Chaudhari, V Gajbhiye Journal of Pharmaceutical Sciences 112 (5), 1450-1459, 2023 | 11 | 2023 |
| Efficient in vitro and in vivo docetaxel delivery mediated by pH-sensitive LPHNPs for effective breast cancer therapy RS Jadon, G Sharma, NK Garg, N Tandel, KR Gajbhiye, R Salve, ... Colloids and Surfaces B: Biointerfaces 203, 111760, 2021 | 8 | 2021 |
| Hyaluronic acid functionalized liposomes embedded in biodegradable beads for duo drugs delivery to oxaliplatin-resistant colon cancer A Tiwari, V Gajbhiye, A Jain, A Verma, A Shaikh, R Salve, SK Jain Journal of Drug Delivery Science and Technology 77, 103891, 2022 | 7 | 2022 |
| Targeted silencing of the MCL-1 gene using multi-layered dendrimer-based nanoconstructs achieves efficient tumor regression in xenografted mice models P Tambe, R Salve, P Choudhary, P Kumar, S Jadhav, KM Paknikar, ... International Journal of Pharmaceutics 634, 122659, 2023 | 6 | 2023 |
| Carbon nanomaterial-based stimuli-responsive drug delivery strategies R Salve, KR Gajbhiye, RJ Babu, V Gajbhiye Stimuli-Responsive Nanocarriers, 367-392, 2022 | 5 | 2022 |
| Chemosensitivity assessments of curdlan-doped smart nanocomposites containing erlotinib HCl H Bera, YF Abbasi, V Gajbhiye, LL Ping, R Salve, P Kumar, S Kesavan, ... International journal of biological macromolecules 181, 169-179, 2021 | 5 | 2021 |
| Challenges and emerging strategies for next generation liposomal based drug delivery: An account of the breast cancer conundrum A Moudgil, R Salve, V Gajbhiye, BP Chaudhari Chemistry and Physics of Lipids 250, 105258, 2023 | 4 | 2023 |
| An overview of stimuli-responsive nanocarriers: State of the art P Kumar, R Salve, KR Gajbhiye, V Gajbhiye Stimuli-Responsive Nanocarriers, 1-27, 2022 | 4 | 2022 |
| Stimuli-responsive strategies: Role of various molecules/moieties facilitating the design of stimuli-responsive nanocarriers R Salve, P Kumar, KR Gajbhiye, RJ Babu, V Gajbhiye Stimuli-Responsive Nanocarriers, 29-60, 2022 | 4 | 2022 |
| Novel 3-fluoro-4-morpholinoaniline derivatives: Synthesis and assessment of anti-cancer activity in breast cancer cells NA More, NL Jadhao, RJ Meshram, P Tambe, RA Salve, JK Sabane, ... Journal of Molecular Structure 1253, 132127, 2022 | 2 | 2022 |
| Mesoporous silica nanoparticles-based stimuli-triggered drug release systems R Salve, P Kumar, KR Gajbhiye, RA Shende, BP Chaudhari, V Gajbhiye Stimuli-Responsive Nanocarriers, 237-264, 2022 | 1 | 2022 |
| MUC1 aptamer-tethered H40-TEPA-PEG nanoconjugates for targeted siRNA-delivery and gene silencing in breast cancer cells R Salve, N Haldar, A Shaikh, R Samanta, D Sengar, S Patra, V Gajbhiye Frontiers in Bioengineering and Biotechnology 12, 1383495, 2024 | | 2024 |
| Nanoparticle-Mediated Plant Bioactives for Cardiovascular Disease M Kadu, R Salve, KR Gajbhiye, RK Choudhary, V Gajbhiye Advances in Phytonanotechnology for Treatment of Various Diseases, 199-213, 2023 | | 2023 |
| Historical Perspectives and Advances in Phytonanotechnology M Kadu, R Salve, KR Gajbhiye, RK Choudhary, V Gajbhiye Advances in Phytonanotechnology for Treatment of Various Diseases, 1-20, 2023 | | 2023 |
